Nephrotic Syndrome Market Set for Robust Growth During the Forecast Period (2026-2036), Driven by Emerging Therapies and Expanding Research | DelveInsight

The anticipated increase in the nephrotic syndrome market size is driven by advancements in treatment options, greater healthcare access, and a rising prevalence of the condition. Additionally, the expected launch of novel emerging therapies such as Inaxaplin (VX-147) (Vertex...